PROMO.ST Stock - Promore Pharma AB (publ)
Unlock GoAI Insights for PROMO.ST
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|
| Revenue | $99,000 | $417,000 | $14,000 | $3.93M | $2.45M |
| Gross Profit | $-15,845,000 | $-14,895,000 | $-18,202,000 | $-16,370,000 | $-22,005,000 |
| Gross Margin | -16005.1% | -3571.9% | -130014.3% | -416.8% | -899.3% |
| Operating Income | $-26,603,000 | $-26,694,000 | $-29,094,000 | $-29,069,000 | $-32,676,000 |
| Net Income | $-26,619,000 | $-26,962,000 | $-29,950,000 | $-28,661,000 | $-32,483,000 |
| Net Margin | -26887.9% | -6465.7% | -213928.6% | -729.7% | -1327.5% |
| EPS | $-0.44 | $-0.57 | $-103.32 | $-1.33 | $-1.58 |
Promore Pharma AB (publ), a biopharmaceutical company, develops peptide-based drug candidates in Sweden and internationally. Its product candidates include PXL01 that is in Phase IIa study for the prevention of post-surgical adhesions and scars, and for the prevention of dermal scars, as well as for tendon repair surgery in the hand; and LL-37, which is in Phase IIb clinical studies for treating patients with venous leg ulcers, stimulate the healing of chronic wounds, and for the treatment of diabetic foot ulcers. It entered into a cooperation agreement with Fidia Farmaceutici S.p.A. for the production of hyaluronic acid syringes. The company was formerly known as Lipopeptide AB and changed its name to Promore Pharma AB (publ) in January 2017. Promore Pharma AB (publ) was founded in 2002 and is headquartered in Solna, Sweden.
Visit WebsiteEarnings History & Surprises
PROMO.STEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q3 2023 | Sep 30, 2023 | — | $-0.06 | — | — |
Q2 2023 | Jun 30, 2023 | — | $-0.06 | — | — |
Q1 2023 | Mar 31, 2023 | — | $-0.12 | — | — |
Q4 2022 | Dec 31, 2022 | — | $-0.11 | — | — |
Q3 2022 | Sep 30, 2022 | — | $-0.09 | — | — |
Q2 2022 | Jun 30, 2022 | — | $-0.10 | — | — |
Q1 2022 | Mar 31, 2022 | — | $-0.14 | — | — |
Q1 2022 | Feb 24, 2022 | — | $-0.12 | — | — |
Q4 2021 | Nov 23, 2021 | — | $-0.22 | — | — |
Q3 2021 | Sep 30, 2021 | — | $-0.11 | — | — |
Q1 2021 | Mar 31, 2021 | — | $-0.19 | — | — |
Q4 2020 | Dec 31, 2020 | — | $-0.21 | — | — |
Q3 2020 | Sep 30, 2020 | — | $-0.22 | — | — |
Q2 2020 | Jun 30, 2020 | — | $-0.18 | — | — |
Q1 2020 | Mar 31, 2020 | — | $-0.19 | — | — |
Q1 2020 | Feb 18, 2020 | — | $-0.39 | — | — |
Q4 2019 | Nov 22, 2019 | — | $-0.33 | — | — |
Q3 2019 | Aug 28, 2019 | — | $-0.35 | — | — |
Q2 2019 | May 21, 2019 | — | $-0.27 | — | — |
Q1 2019 | Feb 26, 2019 | — | $-0.30 | — | — |
Latest News
Frequently Asked Questions about PROMO.ST
What is PROMO.ST's current stock price?
What is the analyst price target for PROMO.ST?
What sector is Promore Pharma AB (publ) in?
What is PROMO.ST's market cap?
Does PROMO.ST pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to PROMO.ST for comparison